Search results
New synthetic biomarker technology differentiates between prior Zika and dengue infections
Medical Xpress· 9 hours agoA newly discovered Zika virus-specific synthetic molecule is capable of differentiating Zika-immune...
Valneva Reports First Quarter 2024 Financial Results and Provides Corporate Updates
Benzinga· 7 days agoValneva Reports First Quarter 2024 Financial Results and Provides Corporate Updates Q1 financial highlights Total revenues of €32.8 million, including sales of €32.1 million, on track to meet
Valneva Reports Further Positive Pivotal Phase 3 Data in Adolescents for its Single-Shot Chikungunya...
Benzinga· 23 hours agoSaint-Herblain (France), May 13, 2024 – Valneva SE VALNVLA, a specialty vaccine company, today reported further positive pivotal Phase 3 data in adolescents for its single-shot chikungunya & ...
VBI Vaccines (NASDAQ:VBIV) Earns Sell Rating from Analysts at StockNews.com
ETF DAILY NEWS· 2 days agoStockNews.com started coverage on shares of VBI Vaccines (NASDAQ:VBIV – Get Free Report) in a research report issued on Sunday. The brokerage set a “sell” rating on the biopharmaceutical company ...
Moderna (NASDAQ:MRNA) Stock Price Down 3.4% Following Insider Selling
ETF DAILY NEWS· 6 days agoShares of Moderna, Inc. (NASDAQ:MRNA – Get Free Report) dropped 3.4% during trading on Monday after an insider sold shares in the company. The company traded as low as $120.38 and last traded ...
How to fight onslaught of invasive, disease-carrying mosquitos? More mosquitos
Los Angeles Daily News· 4 days agoThis novel use of biological bug warfare begins on Thursday, May 16, when 60,000 irradiated male...